More Promise?

The Supreme Court of Canada will release its leave to appeal decision on Thursday in AstraZeneca Canada Inc., et al. v. Apotex Inc., et al. (Esomeprazole), which considers, among other things, the promised utility doctrine in Canada. SCC File #36654 on appeal from 2015 FCA 158.

More information on this and other intellectual property proceedings at the Supreme Court are available on my Supreme Court litigation page.